Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials
JW Belk, MJ Kraeutler, DA Houck… - … American journal of …, 2021 - journals.sagepub.com
Background: Platelet-rich plasma (PRP) and hyaluronic acid (HA) are 2 nonoperative
treatment options for knee osteoarthritis (OA) that are supposed to provide symptomatic …
treatment options for knee osteoarthritis (OA) that are supposed to provide symptomatic …
Applications of the regenerative capacity of platelets in modern medicine
E Cecerska-Heryć, M Goszka, N Serwin… - Cytokine & growth factor …, 2022 - Elsevier
Platelets produce platelet growth factors such as PDGF, IGF-1, EGF-, HGF, TGFβ, bFGF, and
VEGF, which are crucial in regulating all stages of the wound healing process. The source of …
VEGF, which are crucial in regulating all stages of the wound healing process. The source of …
Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE …
Importance Most clinical guidelines do not recommend platelet-rich plasma (PRP) for knee
osteoarthritis (OA) because of lack of high-quality evidence on efficacy for symptoms and …
osteoarthritis (OA) because of lack of high-quality evidence on efficacy for symptoms and …
[HTML][HTML] Osteoarthritis year in review 2018: clinical
LA Mandl - Osteoarthritis and cartilage, 2019 - Elsevier
Osteoarthritis (OA) is the most common joint disease in the world, with an age-associated
increase in both incidence and prevalence. Clinical and epidemiologic research is crucial to …
increase in both incidence and prevalence. Clinical and epidemiologic research is crucial to …
Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: results at 5 years of a double-blind, randomized controlled trial
A Di Martino, B Di Matteo, T Papio… - … American Journal of …, 2019 - journals.sagepub.com
Background: Platelet-rich plasma (PRP) injections have been proposed as a new
conservative option for knee degeneration to provide symptomatic relief and delay surgical …
conservative option for knee degeneration to provide symptomatic relief and delay surgical …
[HTML][HTML] Intervertebral disc diseases PART 2: a review of the current diagnostic and treatment strategies for intervertebral disc disease
PH Wu, HS Kim, IT Jang - International journal of molecular sciences, 2020 - mdpi.com
With an aging population, there is a proportional increase in the prevalence of intervertebral
disc diseases. Intervertebral disc diseases are the leading cause of lower back pain and …
disc diseases. Intervertebral disc diseases are the leading cause of lower back pain and …
PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials
Objective To evaluate effectiveness, in terms of patient-reported outcome measures, of
platelet-rich plasma (PRP) injections for knee osteoarthritis compared to placebo and other …
platelet-rich plasma (PRP) injections for knee osteoarthritis compared to placebo and other …
[HTML][HTML] Mechanisms of osteoarthritic pain. Studies in humans and experimental models
A Eitner, GO Hofmann, HG Schaible - Frontiers in molecular …, 2017 - frontiersin.org
Pain due to osteoarthritis (OA) is one of the most frequent causes of chronic pain. However,
the mechanisms of OA pain are poorly understood. This review addresses the mechanisms …
the mechanisms of OA pain are poorly understood. This review addresses the mechanisms …
[HTML][HTML] Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and …
J Zhao, H Huang, G Liang, L Zeng, W Yang… - BMC musculoskeletal …, 2020 - Springer
Background Studies have shown that the combined application of hyaluronic acid (HA) and
platelet-rich plasma (PRP) can repair degenerated cartilage and delay the progression of …
platelet-rich plasma (PRP) can repair degenerated cartilage and delay the progression of …
Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics
Introduction: Osteoarthritis (OA) is a leading cause of pain and disability among adults with a
current prevalence of around 15% and a predicted prevalence of 35% in 2030 for …
current prevalence of around 15% and a predicted prevalence of 35% in 2030 for …